In cases of a negative RT-QuIC result and elevated t-tau in a patient with rapidly progressive cognitive impairment, the differential diagnosis between CJD and atypical AD is also supported by the combined analyses of CSF p-tau, Aβ42 and possibly total-PrP [1, 21]. This evidence concerns the gene MAPT and Creutzfeldt Jacob disease.